Anderson Kenneth Carl bought CCCC
June 1, 2026 · Form 4 insider transaction
Anderson Kenneth Carl bought 1,070 shares of C4 Therapeutics, Inc. at $2.11 per share, a transaction worth $2.3K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,070
Price
$2.11
Total value
$2.3K
InsiderAnderson Kenneth Carl
Role—
CompanyC4 Therapeutics, Inc. (CCCC)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 1, 2026
Filing dateJune 4, 2026
Shares owned after69,300
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reported transaction represents the exercise of a stock option for cash. No shares were sold in connection with the exercise.